L-Dopa and Cardiac Arrhythmia (Cont.)

L. Landsberg*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Scopus citations


To the Editor: I read with interest the letter of Drs. Mars and Krall in the December 16, 1971, issue of the Journal (285:1437, 1971) and should like to call attention to some recent work in our laboratory.1,2 which may be pertinent to their findings and which may explain the arrhythmogenic potential of L-dopa. In experiments using 3H-norepinephrine as a tracer, L-dopa administered to Sprague-Dawley rats resulted in a significant dose-related release of norepinephrine (NE) from the sympathetic nerve endings of the heart. Ganglionic blockade did not prevent the release of cardiac NE, thus indicating a direct effect of L-dopa. No extract is available for articles shorter than 400 words.

Original languageEnglish (US)
Pages (from-to)218
Number of pages1
JournalNew England Journal of Medicine
Issue number4
StatePublished - Jan 27 1972

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'L-Dopa and Cardiac Arrhythmia (Cont.)'. Together they form a unique fingerprint.

Cite this